Hint mode is switched on Switch off

Adagene, American depositary receipt (ADR)
ADAG, US0053291078

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Adagene, сountry — China
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in
API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Adagene Inc operates as an antibody discovery and engineering company. The Company offers a smart antibody technology, which increases success rates, substantially accelerates time to market, and reduces the costs associated with developing a therapeutic antibody.
  • Issuer
  • Full borrower / issuer name
    Adagene Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ADAG
  • Placement
    09.02.2021
  • Lock up period
    180
  • Number of papers
    7,354,000
  • Volume of raised funds
    139.73 mln USD
  • Placement share
    17.43%
  • Final placement price
    19 USD
  • Price change since placement date
    -100%
  • By capitalization
    801.42 mln USD

IFRS/US GAAP reports

2025
2024
2023
2022
2021
2020
Show more Hide

Related Stock indices

Registration is required to get access.